Get startedLog in
    Picture of Shandong Boan Biotechnology logo

    6955 — Shandong Boan Biotechnology News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Shandong Boan Biotechnology Says Approval For Initiating Clinical Trial For Novel ADC Candidate In China

    Picture of Shandong Boan Biotechnology logoShandong Boan Biotechnology
    25/07/2024 11:43
    July 25 (Reuters) - Shandong Boan Biotechnology Co Ltd
 6955.HK :
    * APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR NOVEL
ADC
CANDIDATE BA1302 IN CHINA


Further company coverage:  6955.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shandong Boan Biotechnology

    See all news